Malave Luis

DirectorGlucotrack, Inc. (GCTK) · full profile →Form 4 · filed Mar 31, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
17
12 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2025Grant(A)2K$0144K
Mar 12, 2025Option exercise(X)134K$0142K
Nov 14, 2024Conversion(C)7K$31.20$215K8K
Apr 8, 2024Grant(A)489$01K
Dec 31, 2023Grant(A)362$0634
Apr 20, 2023Grant(A)121$0272
Jan 9, 2023Grant(A)29$0151
Oct 4, 2022Grant(A)44$0122
Jun 30, 2022Grant(A)34$078
Mar 31, 2022Grant(A)25$044
Dec 31, 2021Grant(A)11$019
Sep 30, 2021Grant(A)8$08

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2025Option exercise(X)0$0
Nov 14, 2024Grant(A)00
Nov 14, 2024Grant(A)7K7K
Nov 14, 2024Conversion(C)7K$214831.00$1.5B7K
Jul 18, 2024Buy(P)7K$200000.00$1.4B0

Transaction Codes

A
Grant / award
X
Exercise of in-the-money derivative
C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001474506-25-000071) within minutes of acceptance. Every field above traces to the original document. Verify it directly: